BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.020
+0.686 (20.58%)
At close: Aug 6, 2026
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $71.26 million as of August 6, 2026. Its market cap has decreased by -60.79% in one year.
Market Cap
71.26M
Enterprise Value
60.84M
Revenue
37.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.02
ChartMarket Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 71.26M, an increase of 1,392.59%. That is a compound annual growth rate of 17.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 71.26M | 11.33% |
| Dec 31, 2025 | 64.01M | -72.22% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 105.08M |
| HST Global | 99.00M |
| Cell Source | 60.47M |
| Nuo Therapeutics | 48.41M |
| Vicapsys Life Sciences | 46.94M |
| BetterLife Pharma | 39.66M |
| Arch Biopartners | 38.93M |
| ProText Mobility | 36.92M |